Tobias Neumann

Dr. Tobias Neumann

General Practice Koeln-Vogelsang, familienmedizin.koeln, Cologne, North Rhine-Westphalia, Germany
orcid
Owner of familienmedizin.koeln

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2011 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
ECErol Cavus
Erol Cavus
TNTobias Neumann
Tobias Neumann
VDVolker Doerges
Volker Doerges
TMThora Moeller
Thora Moeller
ESEdwin Scharf
Edwin Scharf
GSGoetz Serocki
Goetz Serocki
In the present preliminary study we evaluated the C-MAC® D-Blade (Karl Storz, Tuttlingen, Germany), a new videolaryngoscopic C-MAC blade for difficult intubation, during both routine and difficult intubations. First, both the conventional direct laryngoscopy and the D-Blade were used in 15 consecutive patients with normal airways during routine induction of anesthesia. Second, the D-Blade was used as a rescue device in 20 of 300 (6.7%) consecutive patients, when conventional direct laryngoscopy failed. In the 15 patients during routine induction of anesthesia, with direct laryngoscopy, a Cormack-Lehane (C/L) grade 1 and grade 2a view was seen in 7 and 8 patients, respectively. It was possible to insert the D-Blade and to get a video view of the glottis on the first attempt in all patients; with the D-Blade, all 15 patients had a C/L 1 view. The time to successful intubation with the D-Blade was 15 (8-26) seconds (median (range)). In the 20 patients, in whom unexpected difficulty with direct laryngoscopy was observed, C/L grades 3 and 4 were present in 15 and 5 patients, respectively. With the use of the D-Blade, indirect C/L video view improved to C/L class 1 in 15 patients, and to 2a in 5 patients, respectively. The time from touching the laryngoscope to optimal laryngoscopic view was 11 (5-45) seconds and for successful intubation 17 (3-80) seconds. In all 35 patients, with the D-Blade no direct view of the glottis was possible and subsequently a semiflexible tube guide was required.

1 October 2016 in Critical Care Medicine
Verified
Journal Article
Closed access
SBStefan Bergt
Stefan Bergt
MGMatthias Gruenewald
Matthias Gruenewald
CBClaudia Beltschany
Claudia Beltschany
AGAndrea Grub
Andrea Grub
TNTobias Neumann
Tobias Neumann
PMPatrick Meybohm
Patrick Meybohm
Objectives: The fibrin-derived peptide Bβ15–42 (FX06) has been proven to attenuate ischemia/reperfusion injury. We tested the hypothesis that Bβ15–42 improves survival rate and neurocognitive recovery after cardiopulmonary resuscitation. Design: Pig and mouse model of cardiopulmonary resuscitation. Setting: Two university hospitals. Subjects: Pigs and mice. Interventions: Pigs (n = 16) were subjected to 8-minute cardiac arrest. Successful resuscitated pigs (n = 12) were randomized either to 3 mg/kg Bβ15–42 followed by a continuous infusion of 1 mg/kg/hr for 5 hours (pFX06; n = 6) or the control group (pCONTROL; n = 6). Cardiac damage, function, and hemodynamics were recorded up to 8 hours. Mice (n = 52) were subjected to 4-minute cardiac arrest followed by cardiopulmonary resuscitation, and randomized either to two boli of 2.4 mg/kg Bβ15–42 (mFX06; n = 26) or the control group (mCONTROL; n = 26). Fourteen-day survival rate, neurocognitive function, and endothelial integrity (additional experiment with n = 26 mice) were evaluated. Measurements and Main Results: Bβ15–42 reduced cumulative fluid intake (3,500 [2,600–4,200] vs 6,800 [5,700–7,400] mL; p = 0.004) within 8 hours in pigs. In mice, Bβ15–42 improved 14-day survival rate (mFX06 vs mCONTROL; 11/26 vs 6/26; p < 0.05) and fastened neurocognitive recovery in the Water-Maze test (15/26 vs 9/26 mice with competence to perform test; p < 0.05). Bβ15–42-treated mice showed a significant higher length of intact pulmonary endothelium and reduced pulmonary leukocyte infiltration. Conclusions: This study confirms the new concept of an important role of fibrin derivatives in global ischemia/reperfusion injury, which can be attenuated by the fibrin-derived peptide Bβ15–42.

26 September 2012 in Journal of the American Heart Association
Verified
Journal Article
Open access
TNTobias Neumann
Tobias Neumann
MGMatthias Gruenewald
Matthias Gruenewald
CLChristoph Lauenstein
Christoph Lauenstein
TDTobias Drews
Tobias Drews
TITimo Iden
Timo Iden
PMPatrick Meybohm
Patrick Meybohm
Background: Recently, it has been demonstrated that rescuers could safely provide a low, static downward force in direct contact with patients during elective cardioversion. The purpose of our experimental study was to investigate whether shock delivery during uninterrupted chest compressions may have an impact on cardiopulmonary resuscitation ( CPR ) quality and can be safely performed in a realistic animal model of CPR . Methods and Results: Twenty anesthetized swine were subjected to 7 minutes of ventricular fibrillation followed by CPR according to the 2010 A merican H eart A ssociation G uidelines. Pregelled self‐adhesive defibrillation electrodes were attached onto the torso in the ventrodorsal direction and connected to a biphasic defibrillator. Animals were randomized either to (1) hands‐on defibrillation, where rescuers wore 2 pairs of polyethylene gloves and shocks were delivered during ongoing chest compressions, or (2) hands‐off defibrillation, where hands were taken off during defibrillation. CPR was successful in 9 out of 10 animals in the hands‐on group (versus 8 out of 10 animals in the hands‐off group; not significant). In the hands‐on group, chest compressions were interrupted for 0.8% [0.6%; 1.4%] of the total CPR time (versus 8.2% [4.2%; 9.0%]; P =0.0003), and coronary perfusion pressure was earlier restored to its pre‐interruption level ( P =0.0205). Also, rescuers neither sensed any kind of electric stimulus nor did H olter ECG reveal any serious cardiac arrhythmia. Conclusions: Hands‐on defibrillation may improve CPR quality and could be safely performed during uninterrupted chest compressions in our standardized porcine model.

1 March 2020 in Resuscitation Plus
Verified
Journal Article
Open access
TNTobias Neumann
Tobias Neumann
SFSimon-Richard Finke
Simon-Richard Finke
MHMaja Henninger
Maja Henninger
SLSebastian Lemke
Sebastian Lemke
BHBen Hoepfner
Ben Hoepfner
TAThorsten Annecke
Thorsten Annecke
Prognosis in out-of-hospital cardiac arrest (OHCA) depends on cardiopulmonary resuscitation (CPR) duration. Therefore, the optimal biphasic defibrillation waveform shows high conversion rates besides low energy. Matthew Fishler theoretically predicted it to be truncated ascending exponential. We realised a prototypic defibrillator and compared ascending with conventional rectangular waveforms in modelled OHCA and CPR. Approved by the authorities, 57 healthy swine (Landrace ​× ​Piétrain) were randomised to ASCDefib (n 26) or CONVDefib (n 26). Five swine served as sham control. We induced ventricular fibrillation (VF) electrically in anaesthetised swine randomised to ASCDefib or CONVDefib and discontinued mechanical ventilation. After 5 ​min of untreated cardiac arrest, we started CPR with mechanical chest compressions and ventilation. We performed transthoracic biphasic defibrillations after 2, 4, 6 and 8 ​min CPR targeting 4 ​J/kg in either group. Depending on the randomised group, the defibrillation protocol was either three ascending followed by one rectangular waveform (ASCDefib) or three rectangular followed by one ascending waveform (CONVDefib). Under our model-specific conditions, VF was initially terminated by 13/80 ascending waveforms and 13/79 rectangular waveforms and persistent return of spontaneous circulation was achieved in 8/26 (ASCDefib) vs. 10/26 (CONVDefib) animals. Mean current rather than waveform design was predictive for defibrillation success in a generalised linear model. Contrary to theoretical assumptions, transthoracic biphasic defibrillation with ascending waveforms is not superior to rectangular waveforms in modelled OHCA. We advocate defibrillation dosage to be guided by current, that has proven its predictive value again. 84–02.04.2017.A176.

26 August 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
HDHendrik Drinhaus
Hendrik Drinhaus
CMChristoph Mallmann
Christoph Mallmann
CCCorvin Cleff
Corvin Cleff
TNTobias Neumann
Tobias Neumann
CDChristina Daniels
Christina Daniels
TAThorsten Annecke
Thorsten Annecke
Background/Objectives: “Accelerated Recovery after Surgery” (ARAS) programs for esophagectomy aim to shorten the perioperative course without increases in morbidity or mortality. In such programs, the prediction and early detection of perioperative complications is essential, as ICU observation times are limited. We evaluated two potential laboratory markers as predictors for postoperative complications: shedding of the endothelial glycocalyx and the veno-arterial CO2-gap as indicators of microcirculatory disturbances. Methods: In total, 26 patients undergoing hybrid Ivor Lewis esophagectomy within an ARAS program were included. Macrocirculatory conditions were kept stable by enhanced hemodynamic monitoring (PiCCO). Glycocalyx shedding parameters (Syndecan-1, heparan sulfate, hyaluronic acid) and a panel of inflammatory mediators were measured preoperatively, upon ICU-admission, and on the first postoperative day. The veno-arterial CO2-gap was calculated at induction of anesthesia, during laparoscopy, and upon admission to the ICU. Results: Complications (Dindo-Clavien ≥3) occurred in n = 16 (62%) patients. From preoperatively to admission to the ICU, Syndecan-1 (29 pre-op to 56 ng/mL at ICU-admission) and Interleukins 1b (1.2 to 1.4 pg/mL), 6 (1.3 to 19.9 pg/mL), 8 (5.2 to 19.9 pg/mL), and 10 (0.50 to 1.33 pg/mL) increased, indicating a temporary increase in inflammation and glycocalyx shedding during surgery. A difference between patients with or without complications could not be detected. There was also no difference in the veno-arterial CO2-gap between the two groups (median of 6.8 mmHg in all patients, 6.7 in patients with complications, 7.8 in patients without complications). Conclusions: Signs of microcirculatory dysfunctions and inflammation occurred during esophagectomy within an ARAS protocol with tightly controlled hemodynamics. Increases in Syndecan-1 and the veno-arterial CO2-gap could not predict perioperative complications.

22 November 2011 in Circulation
Verified
Journal Article
Closed access
TNTobias Neumann
Tobias Neumann
MGMatthias Gruenewald
Matthias Gruenewald
CLChristoph Lauenstein
Christoph Lauenstein
PVPeter Voelk
Peter Voelk
ARAnne Rosenthal
Anne Rosenthal
PMPatrick Meybohm
Patrick Meybohm
Background: It has been demonstrated that hands-on chest compressions (CC) during cardioversion in humans can be safely performed. [1] We assessed the hypothesis that it will be safe during CPR and improves its quality. Methods: Twenty anesthetized swine were subjected to V-fib and subsequent CPR. Self-adhesive defibrillation electrodes were used with a biphasic defibrillator (corpuls3, G. Stemple GmbH, Germany). Swine were randomized either to i) hands-on defibrillation, where rescuers wore polyethylene gloves and defibrillation was delivered during ongoing CC, or ii) conventional hands-off defibrillation. In the hands-on group CC were interrupted only for rhythm analysis, when a marked increase of arterial blood pressure or endtidal CO 2 was observed suggesting spontaneus circulation. Holter ECG was registered to analyze potential cardiac arrhythmias in rescuers. Results: ROSC was achieved in 9 out of 10 swine in the hands-on group compared to 8 out of 10 (ns). Interruptions in CC were reduced by hands-on technique (p < 0.001) and coronary perfusion pressure (CorPP) was earlier restored to the pre-shock level (p = 0.014). In only 13 of 34 cases (38 %) interruption of hands-on CPR revealed a stable spontaneous circulation. Transthoracic impedance was not significantly different (hands-on 66 ± 40 Ohm vs. hands-off 63 ± 24 Ohm, p = 0.720). During all 37 hands-on shocks rescuers never felt any kind of electric stimulus. Holter ECG analysis did not reveal any serious arrhythmia during hands-on CPR (SVES/h: 5.0 ± 5.4, PVC/h: 0.2 ± 0.5). Conclusions: Hands-on defibrillation shortens CPR pauses and fastens restoration of CorPP that is predictive for CPR outcome. More sophisticated ECG filters may enable rhythm analysis during ongoing CC to avoid unnecessary pauses. Hands-on CPR can be safely performed but clinical studies are needed before implementation into daily practice. References: 1. Lloyd MS et al. Circulation 2008; 117: 2510-4